Loading clinical trials...
Loading clinical trials...
A Multicenter, Pivotal, Randomized Controlled Trial Comparing the Safety and Efficacy of an Automated Insulin Delivery System With the Standard of Care in Adults With Type 2 Diabetes (EMBRACE-T2D)
Conditions
Interventions
An AID System.
Standard of Care (SC)
Locations
9
United States
Stanford
Palo Alto, California, United States
Diablo Research
Walnut Creek, California, United States
Indiana Universtiy School of Medicine
Indianapolis, Indiana, United States
NYC Research
Long Island City, New York, United States
Icahn School of Medicine at Mt. Sinai
New York, New York, United States
UT Southwestern
Dallas, Texas, United States
Start Date
January 1, 2025
Primary Completion Date
March 1, 2026
Completion Date
May 1, 2026
Last Updated
December 16, 2024
NCT07232537
NCT06815081
NCT06003153
NCT06278207
NCT07051005
NCT07296484
Lead Sponsor
Embecta Corp.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions